MAPT and prion disease: However, there is also a key difference to prion diseases: mice expressing human P301L tau in the entorhinal cortex, crossed onto mice with tau‐null background show tau propagation and accumulation both in the presence and absence of endogenous tau, although lack of endogenous tau greatly reduces toxicity and brain atrophy 61.